Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (5607)	9/12/1998 2:29:00 AM
From: Rocketman	Respond to of 9719

No way, let's sit tight on AVIR and see what the FDA has to say. It isn't like we get to use the loss on our taxes. I still think there was a massive overreaction and they'll work it out with the FDA. I'm in this one for the long haul and I think biotechs are on the road to recovery. BGEN is a rocket! Rman

To: Vector1 who wrote (5607)	9/12/1998 2:37:00 AM
From: Rocketman	Read Replies (2) \| Respond to of 9719

Man there are some bargains out there. GSII trades at less than 70% of book value, and 75% of cash value. 40 million in cash with a 30 million market cap and products in the market. Granted they are slow to be adopted, but they are still great products. Time for someone to step up and acquire these sorts of companies. Looking to acquire any med devices any time soon? Rman